MyFinsight
Home
Blog
About
Contact
eypt: the balance sheet
Download
Download image
Inventory
$2,110K
Prepaid expenses and
other current assets
$8,929K
Accounts and other
receivables, net
$1,045K
Marketable securities
$129,445K
Cash and cash
equivalents
$74,577K
Other assets
$5,918K
Restricted cash
$150K
Operating lease
right-of-use assets
$20,660K
Property and equipment,
net
$8,861K
Total current assets
$216,106K
Total assets
$251,695K
Total liabilities and
stockholders' equity
$251,695K
Total stockholders'
equity
$200,182K
Total liabilities
$51,513K
Accumulated deficit
-$1,037,369K
Accumulated other
comprehensive income (loss)
$919K
Additional paid-in capital
$1,236,562K
Other noncurrent
liabilities
$118K
Operating lease
liabilities - noncurrent
$21,301K
Total current
liabilities
$30,094K
Common stock, .001 par
value, 300,000,000...
$70K
Other current
liabilities
$2,075K
Accrued expenses
$17,943K
Accounts payable
$10,076K
Back
Back
Balance Sheet
source: myfinsight.com
EyePoint Pharmaceuticals, Inc. (EYPT)
EyePoint Pharmaceuticals, Inc. (EYPT)